登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Clinical information of good responders and poor responders.
Clinical information of good responders and poor responders.
收藏
Figshare
2021-03-10 更新
2026-04-28 收录
临床疗效评估
患者分层分析
数据链接:
https://figshare.com/articles/dataset/Clinical_information_of_good_responders_and_poor_responders_/14236303
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Clinical information of good responders and poor responders.
应用场景:
创建时间:
2021-03-10
相关数据集
Therapeutic Responses to Quinine and Clindamycin in Multidrug-Resistant Falciparum Malaria
疟疾治疗
临床疗效评估
Therapeutic responses to clindamycin in combination with quinine were assessed in adult Thai patients with uncomplicated multidrug-resistant Plasmodium falciparum malaria. In total 204 patients were r
PubMed Central
2
0
Treatment response of recovered WaSt and non-WaSt children admitted to OTC, Karamoja.
儿童急性营养不良治疗
临床疗效评估
Treatment response of recovered WaSt and non-WaSt children admitted to OTC, Karamoja.
NIAID Data Ecosystem
1
0
Clinical characteristics during PLIS stratified by intensive care unit versus nonintensive care unit.
重症监护临床特征
患者分层分析
Clinical characteristics during PLIS stratified by intensive care unit versus nonintensive care unit.
NIAID Data Ecosystem
1
0
A study of S-1 with radiation therapy with local advanced colorectal cancer
结肠直肠癌
临床疗效评估
Interventions: 1:different drug;2:S1 capsule Primary outcome(s): R0 rate;anus reservation Study Design: Randomized parallel controlled trial
NIAID Data Ecosystem
2
0
Study on the combined scheme of Quxie Capsule in the third-line treatment of metastatic colorectal cancer and the characteristics of the dominant population
转移性结直肠癌治疗
临床疗效评估
Interventions: Treatment group:Quxie capsule + Furaquitinib + Regofini + TAS-102;control group:Furaquitinib + Regofini + TAS-102 Primary outcome(s): overall survival (OS) Study Design: Non randomized
NIAID Data Ecosystem
1
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广